New Delhi: The domestic pharma industry is staring at a loss ranging between Rs 2,500 crore and Rs 5,000 crore due to the various supply and freight movement disruptions owing…
USA: Dupilumab significantly reduced itch and hive severity in patients with chronic spontaneous urticaria (CSU) who remained symptomatic despite antihistamine therapy, findings from the phase 3 LIBERTY-CSU CUPID trials published…
Bengaluru: The U.S. Food and Drug Administration on Thursday approved Johnson & Johnson's treatment for a type of blood cancer, making it the third drug cleared under the agency's new…
Extremely preterm birth (EPB), defined as delivery before 28 weeks of gestation, poses significant challenges in maternal–fetal medicine, affecting approximately 2–5 per 1,000 pregnancies. This condition is associated with severe…
USA: A phase 2a pilot trial evaluating dual costimulatory blockade with dazodalibep plus belatacept suggests this approach may improve immunosuppression adherence and offer a non-calcineurin alternative for kidney transplant recipients.…
A simple combination of daily physical exercise and protein-rich nutritional drinks appears to offer significant health benefits for people with dementia. In a new study from Karolinska Institutet, not only…
Moderna's long-term strategy, an FDA fast-track for Janssen, and other biotech news from The Readout
Postoperative pulmonary complications (PPCs) are a major concern for children undergoing thoracic surgery—especially when one-lung ventilation (OLV) is required. Unlike adults, children have unique respiratory anatomy and physiology that make…
The HighLife Transcatheter Mitral Valve Replacement (TMVR) system achieves a 90% technical success rate and effectively eliminates leakage in 88% of high-risk patients, as a recent study has shown.These findings…
China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded